Lars Farde

34.5k total citations · 5 hit papers
467 papers, 24.2k citations indexed

About

Lars Farde is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health. According to data from OpenAlex, Lars Farde has authored 467 papers receiving a total of 24.2k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Cellular and Molecular Neuroscience, 174 papers in Radiology, Nuclear Medicine and Imaging and 127 papers in Psychiatry and Mental health. Recurrent topics in Lars Farde's work include Neurotransmitter Receptor Influence on Behavior (159 papers), Medical Imaging Techniques and Applications (145 papers) and Neuroscience and Neuropharmacology Research (133 papers). Lars Farde is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (159 papers), Medical Imaging Techniques and Applications (145 papers) and Neuroscience and Neuropharmacology Research (133 papers). Lars Farde collaborates with scholars based in Sweden, United States and Denmark. Lars Farde's co-authors include Christer Halldin, Göran Sedvall, Håkan Hall, Anna Nordström, Per Karlsson, Lars Bäckman, Andrea Varrone, Balázs Gulyás, E. Ehrin and Carl‐Gunnar Swahn and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Lars Farde

461 papers receiving 23.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

1992 1.1k citations Lars Farde profile →
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET

1986 645 citations Lars Farde, Göran Sedvall et al. Science profile →
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

1999 588 citations Lars Farde et al. profile →
The correlative triad among aging, dopamine, and cognition: Current status and future prospects

2006 586 citations Lars Farde et al. profile →
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs

1988 486 citations Lars Farde profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Lars Farde	11.2k	7.5k	5.7k	5.4k	5.1k	467	24.2k
Marc Laruelle	12.2k 1.1×	5.5k 0.7×	5.7k 1.0×	3.3k 0.6×	5.3k 1.0×	245	20.7k
Christer Halldin	9.5k 0.9×	4.1k 0.6×	3.7k 0.7×	6.3k 1.2×	6.7k 1.3×	668	24.1k
Robert B. Innis	10.6k 1.0×	4.0k 0.5×	3.8k 0.7×	4.2k 0.8×	6.5k 1.3×	412	25.7k
Jean Logan	16.2k 1.5×	6.7k 0.9×	8.8k 1.6×	3.4k 0.6×	6.5k 1.3×	272	32.9k
Alan A. Wilson	8.3k 0.7×	3.8k 0.5×	3.3k 0.6×	3.1k 0.6×	4.4k 0.8×	328	19.0k
Sylvain Houle	8.5k 0.8×	4.8k 0.6×	10.5k 1.9×	3.3k 0.6×	3.6k 0.7×	421	28.1k
Anissa Abi‐Dargham	9.9k 0.9×	6.1k 0.8×	6.3k 1.1×	2.4k 0.4×	4.1k 0.8×	228	19.2k
Dean F. Wong	5.9k 0.5×	4.3k 0.6×	3.9k 0.7×	3.5k 0.6×	3.5k 0.7×	421	17.2k
Carol A. Tamminga	7.8k 0.7×	8.2k 1.1×	7.4k 1.3×	2.3k 0.4×	5.6k 1.1×	503	23.2k
John Seibyl	6.3k 0.6×	4.6k 0.6×	3.5k 0.6×	2.5k 0.5×	3.1k 0.6×	312	17.0k

Countries citing papers authored by Lars Farde

Since Specialization

Citations

This map shows the geographic impact of Lars Farde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Farde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Farde more than expected).

Fields of papers citing papers by Lars Farde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Farde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Farde. The network helps show where Lars Farde may publish in the future.

Co-authorship network of co-authors of Lars Farde

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Farde. A scholar is included among the top collaborators of Lars Farde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Farde. Lars Farde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yinlong, Kenneth Dahl, Peter Johnström, et al.. (2024). Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2. ACS Pharmacology & Translational Science. 7(8). 2414–2423.

Jangard, Simon, Nitya Jayaram‐Lindström, Nils Hentati Isacsson, et al.. (2023). Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers. Addiction. 118(6). 1053–1061. 3 indexed citations

Ekman, Simon, Zsolt Cselényi, Andrea Varrone, et al.. (2023). Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non‐small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging study. Clinical and Translational Science. 16(6). 955–965. 7 indexed citations

Cselényi, Zsolt, Johan Wallin, B. Bloth, et al.. (2023). [¹¹C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome. Synapse. 77(4). e22269–e22269. 1 indexed citations

Cselényi, Zsolt, Bengt Andrée, Jacqueline Borg, et al.. (2022). Decreased 5‐HT_1A binding in mild Alzheimer's disease—A positron emission tomography study. Synapse. 76(7-8). e22235–e22235. 12 indexed citations

Tiger, Mikael, Jonas E. Svensson, Benny Liberg, et al.. (2020). [¹¹C]raclopride positron emission tomography study of dopamine‐D_2/3 receptor binding in patients with severe major depressive episodes before and after electroconvulsive therapy and compared to control subjects. Psychiatry and Clinical Neurosciences. 74(4). 263–269. 10 indexed citations

Ekman, Simon, Andrea Varrone, Aurelija Jučaitė, et al.. (2019). P2.14-33 An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases. Journal of Thoracic Oncology. 14(10). S842–S842. 1 indexed citations

Matheson, Granville J., et al.. (2018). Serotonin 5-HT _1A receptor binding and self-transcendence in healthy control subjects—a replication study using Bayesian hypothesis testing. PeerJ. 6. e5790–e5790. 2 indexed citations

Benlloch, J., Antonio J. González, R. Pani, et al.. (2018). The MINDVIEW project: First results. European Psychiatry. 50. 21–27. 22 indexed citations

10.

Forsberg, Anton, Simon Červenka, Malin Jonsson Fagerlund, et al.. (2017). The immune response of the human brain to abdominal surgery. Annals of Neurology. 81(4). 572–582. 74 indexed citations

11.

Tóth, Miklós, Jenny Häggkvist, Anna Bogstedt, et al.. (2017). Differential Effect of APOE Alleles on Brain Glucose Metabolism in Targeted Replacement Mice: An [¹⁸F]FDG-μPET Study. Journal of Alzheimer s Disease Reports. 1(1). 169–180. 15 indexed citations

12.

Tiger, Mikael, Lars Farde, Christian Rück, et al.. (2016). Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder. Psychiatry Research Neuroimaging. 253. 36–42. 21 indexed citations

13.

Tiger, Mikael, Christian Rück, Anton Forsberg, et al.. (2014). Reduced 5-HT1B receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Research Neuroimaging. 223(2). 164–170. 32 indexed citations

14.

Finnema, Sjoerd J., Andrea Varrone, Tzung‐Jeng Hwang, et al.. (2010). Fenfluramine‐induced serotonin release decreases [¹¹C]AZ10419369 binding to 5‐HT_1B‐receptors in the primate brain. Synapse. 64(7). 573–577. 44 indexed citations

15.

Juréus, Anders, Britt‐Marie Swahn, Johan Sandell, et al.. (2010). Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand. Journal of Neurochemistry. 114(3). 784–794. 109 indexed citations

16.

Nord, Magdalena & Lars Farde. (2010). Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia. CNS Neuroscience & Therapeutics. 17(2). 97–103. 107 indexed citations

17.

McNab, Fiona, Andrea Varrone, Lars Farde, et al.. (2009). Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training. Science. 323(5915). 800–802. 408 indexed citations

18.

Farde, Lars, Hiroshi Ito, Carl‐Gunnar Swahn, Victor W. Pike, & Christer Halldin. (1998). Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.. PubMed. 39(11). 1965–71. 114 indexed citations

19.

Swahn, Carl‐Gunnar, et al.. (1994). Metabolism in human plasma determined by HPLC for five 11 C-labelled benzazepines - radioligands for PET examination of the dopamine D-1 receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 35. 540–542. 1 indexed citations

20.

Nyberg, Svante, Lars Farde, Lars I. Eriksson, Christer Halldin, & Bo Eriksson. (1993). 5-HT2 and D2 dopamine receptor occupancy in the living human brain. Psychopharmacology. 110(3). 265–272. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact